Funding Details
- Awarder
- Inbox
- Date Award
- April 22, 2025
- Vertical
- Health Technology
- Funding URL
- View Funding Page
Company Info
- Traction
- Last year, Biolinq secured $58 million in financing for FDA submission and to perform a clinical trial on its glucose sensor.
- Company Description
- Biolinq is a health technology company developing precision multi-analyte wearable biosensors for metabolic health. The company offers a wearable patch that evaluates glucose levels and provides insights into metabolic health for individuals with type 2 diabetes who are not on insulin.
- Market
- Type 2 Diabetes Management
- Location
-
California,
USA
- Coinvestors
- AXA IM Alts, M Ventures, LifeSci Venture Partners, RiverVest Venture Partners, Hikma Ventures, Taisho Pharmaceutical, Features Capital, Aphelion Capital
Links